Kangmei Pharmaceutical Co Ltd (600518):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kangmei Pharmaceutical Co Ltd (600518) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8057
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kangmei Pharmaceutical Co Ltd (Kangmei) is a manufacturer and distributor of herbal medicine. The company provides herbal raw materials and preparations. Kangmei products include Chinese herbal medicine, bottled single product, hong mei life, xinkaihe senate, chinese medicine derived, medicine, chemical drugs and ju huang tea among others. It provides chemical drugs such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, and paracetamol and pseudoephedrine hydrochloride tablets. The company also offers Xinkaihe warm tea, Ginkgo thirty-seven hawthorn polyphenol capsules, Propolis, McKinley card Calcium Iron zinc and selenium chewable tablets, and Happiness red Luzhou nourishing Okuma. It operates in Beijing, Shanghai and Hong Kong. Kangmei is headquartered in Shenzhen, Guangdong, China.

Kangmei Pharmaceutical Co Ltd (600518) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kangmei Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Kangmei Pharma To Acquire Three Hospitals In China For US$82 Million 12
Venture Financing 13
Twist Bioscience Raises Additional USD27 Million in Venture Financing 13
Partnerships 15
Kangmei Pharma Enters into Agreement with BGI Genomics 15
Equity Offering 16
Kangmei Pharma Raises USD1.3 Billion in Private Placement of Shares 16
Kangmei Pharma Plans For Private Placement Of Shares For USD972.4 Million 17
Debt Offering 18
Kangmei Pharma Raises USD154 Million in Public Offering of 7% Notes Due 2021 18
Kangmei Pharma Plans to Raise USD159.21 Million in Public Offering of Bonds 19
Kangmei Pharma Raises USD236.9 Million in Public Offering of 5.38% 2018 First Tranche Notes Due 2018 20
Kangmei Pharma Raises USD454.1 Million in Private Placement of Bonds 21
Kangmei Pharma Raises USD304.7 Million in Public Offering of Third Tranche of 5.47% Notes Due 2022 22
Kangmei Pharma Raises USD300 Million in Public Offering of Second Tranche of 5.29% Notes Due 2022 23
Kangmei Pharma to Raise USD1.6 Billion in Public Offering of Notes 24
Kangmei Pharma Raises USD220.3 Million in Public Offering of Debentures 25
Kangmei Pharma Raises USD369 Million in First Tranche of Public Offering of 3.28% Debentures Due 2017 26
Kangmei Pharma to Raise up to USD391 Million in Private Placement of Bonds 27
Acquisition 28
Kangmei Pharma to Acquire 80% Stake in Huizhou-Based Pharmaceutical Company for USD3.18 million 28
Kangmei Pharma Plans to Acquire Pharmaceutical Company for USD21 Million 29
Kangmei Pharma to Acquire Chongqing Ruitai Pharma for USD12.5 Million 30
Kangmei Pharma to Acquire 80% Stake in Guangdong Xin’ao Pharma for USD9 Million 31
Kangmei Pharma to Acquire Shenzhen Ieman Pharma for USD3.5 Million 32
Kangmei Pharmaceutical Co Ltd – Key Competitors 33
Kangmei Pharmaceutical Co Ltd – Key Employees 34
Kangmei Pharmaceutical Co Ltd – Locations And Subsidiaries 35
Head Office 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kangmei Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Kangmei Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kangmei Pharma To Acquire Three Hospitals In China For US$82 Million 12
Twist Bioscience Raises Additional USD27 Million in Venture Financing 13
Kangmei Pharma Enters into Agreement with BGI Genomics 15
Kangmei Pharma Raises USD1.3 Billion in Private Placement of Shares 16
Kangmei Pharma Plans For Private Placement Of Shares For USD972.4 Million 17
Kangmei Pharma Raises USD154 Million in Public Offering of 7% Notes Due 2021 18
Kangmei Pharma Plans to Raise USD159.21 Million in Public Offering of Bonds 19
Kangmei Pharma Raises USD236.9 Million in Public Offering of 5.38% 2018 First Tranche Notes Due 2018 20
Kangmei Pharma Raises USD454.1 Million in Private Placement of Bonds 21
Kangmei Pharma Raises USD304.7 Million in Public Offering of Third Tranche of 5.47% Notes Due 2022 22
Kangmei Pharma Raises USD300 Million in Public Offering of Second Tranche of 5.29% Notes Due 2022 23
Kangmei Pharma to Raise USD1.6 Billion in Public Offering of Notes 24
Kangmei Pharma Raises USD220.3 Million in Public Offering of Debentures 25
Kangmei Pharma Raises USD369 Million in First Tranche of Public Offering of 3.28% Debentures Due 2017 26
Kangmei Pharma to Raise up to USD391 Million in Private Placement of Bonds 27
Kangmei Pharma to Acquire 80% Stake in Huizhou-Based Pharmaceutical Company for USD3.18 million 28
Kangmei Pharma Plans to Acquire Pharmaceutical Company for USD21 Million 29
Kangmei Pharma to Acquire Chongqing Ruitai Pharma for USD12.5 Million 30
Kangmei Pharma to Acquire 80% Stake in Guangdong Xin'ao Pharma for USD9 Million 31
Kangmei Pharma to Acquire Shenzhen Ieman Pharma for USD3.5 Million 32
Kangmei Pharmaceutical Co Ltd, Key Competitors 33
Kangmei Pharmaceutical Co Ltd, Key Employees 34

List of Figures
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kangmei Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kangmei Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Kangmei Pharmaceutical Co Ltd (600518):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Central Bank Of India:企業の戦略・SWOT・財務分析
    Central Bank Of India - Strategy, SWOT and Corporate Finance Report Summary Central Bank Of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aveda Transportation and Energy Services Inc (AVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Aveda Transportation and Energy Services Inc (Aveda), formerly Phoenix Oilfield Hauling Inc is an oilfield service provider that offers energy transportation and other energy related services. The company provides specialized transportation services and equipment for drilling, exploration, d …
  • Informatica Corporation:企業のM&A・事業提携・投資動向
    Informatica Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Informatica Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Raley’s Family of Fine Stores:企業の戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Econet Wireless Zimbabwe Ltd:企業の戦略・SWOT・財務分析
    Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report Summary Econet Wireless Zimbabwe Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • MOL Hungarian Oil and Gas PLC (MOL):石油・ガス:M&Aディール及び事業提携情報
    Summary MOL Hungarian Oil and Gas PLC (MOL) is an integrated oil and gas company. It explores for, develops and produces crude oil, natural gas and other gas products. The company refines, transports and stores crude oil; markets crude oil products on wholesale and retail basis, and produces and sel …
  • Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析
    Summary Chinese Academy of Sciences (CAS) is a research institute that provides advisory and appraisal services on issues arising from the national economy, social development, and science and technology progress. The institute offers services such as applied research, basic research, experimental d …
  • Rallis India Ltd (RALLIS):企業の財務・戦略的SWOT分析
    Summary Rallis India Ltd (Rallis), a subsidiary of Tata Chemicals Ltd, is an agri-solutions service provider. The company’s business portfolio includes domestic crop protection, international business, contract manufacturing, seeds, plant growth nutrients and agri services. It offers products such a …
  • Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析
    Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Turk Hava Yollari Anonim Ortakligi:戦略・SWOT・企業財務分析
    Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report Summary Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Japan Pulp and Paper Company Limited:企業の戦略・SWOT・財務分析
    Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Ilmarinen Mutual Pension Insurance Co-エネルギー分野:企業M&A・提携分析
    Summary Ilmarinen Mutual Pension Insurance Company (IMPIC) is a financial service provider that offers pension insurance and related services. The company provides services for private customers, which include information on pensions, retiring, pensioner, forms and brochures, pensioner's tax card, a …
  • PhaseRx Inc (PZRX)-製薬・医療分野:企業M&A・提携分析
    Summary PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery te …
  • Mylan NV (MYL)-医療機器分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • SOSINA Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Sosina Exploration Ltd (Sosina), formerly Odegaard UK Ltd is an oil and gas company that offers exploration and development services. The company identifies probable oil and gas accumulations in co-operation with partners within the oil and gas industries. It provides services in geological …
  • Cheng Shin Rubber Ind. Co Ltd (2105):企業の財務・戦略的SWOT分析
    Cheng Shin Rubber Ind. Co Ltd (2105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hemisphere Energy Corp (HME):石油・ガス:M&Aディール及び事業提携情報
    Summary Hemisphere Energy Corp (Hemisphere), formerly Northern Hemisphere Development Corp is an oil and gas company that offers development of oil production reserves. The company offers strategic acquisitions and farm-ins that provide low-risk drilling opportunities. Its operations include heavy o …
  • Continuum Wind Energy Ltd-エネルギー分野:企業M&A・提携分析
    Summary Continuum Wind Energy Ltd (Continuum Wind Energy), a subsidiary of Morgan Stanley Infrastructure Partners LP is a renewable energy company that constructs and develops wind farms and wind energy generation. The company's services include optimization of number of wind turbines to maximize ge …
  • Atwood Oceanics Inc-石油・ガス分野:企業M&A・提携分析
    Summary Atwood Oceanics, Inc. (Atwood) is an offshore drilling contractor, which offers drilling and completion solutions to the oil and gas industry. The company owns a diversified fleet of mobile offshore drilling units in the US Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆